132 related articles for article (PubMed ID: 2330930)
1. An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group.
Rennels MB; Losonsky GA; Young AE; Shindledecker CL; Kapikian AZ; Levine MM
Am J Dis Child; 1990 May; 144(5):601-4. PubMed ID: 2330930
[TBL] [Abstract][Full Text] [Related]
2. Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group.
Pichichero ME; Losonsky GA; Rennels MB; Disney FA; Green JL; Francis AB; Marsocci SM
Pediatr Infect Dis J; 1990 May; 9(5):339-44. PubMed ID: 2162027
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group.
Bernstein DI; Glass RI; Rodgers G; Davidson BL; Sack DA
JAMA; 1995 Apr; 273(15):1191-6. PubMed ID: 7707626
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of Thai infants with rhesus-human reassortant tetravalent oral rotavirus vaccine.
Simasathien S; Migasena S; Samakoses R; Pitisuttitham P; Sangaroon P; Aree C; Bishop R; Bugg H; Davidson BL; Vesikari T
Pediatr Infect Dis J; 1994 Jul; 13(7):590-6. PubMed ID: 7970945
[TBL] [Abstract][Full Text] [Related]
5. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
[TBL] [Abstract][Full Text] [Related]
6. Field trial of rhesus rotavirus vaccine in infants.
Christy C; Madore HP; Pichichero ME; Gala C; Pincus P; Vosefski D; Hoshino Y; Kapikian A; Dolin R
Pediatr Infect Dis J; 1988 Sep; 7(9):645-50. PubMed ID: 2845349
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela.
Pérez-Schael I; Guntiñas MJ; Pérez M; Pagone V; Rojas AM; González R; Cunto W; Hoshino Y; Kapikian AZ
N Engl J Med; 1997 Oct; 337(17):1181-7. PubMed ID: 9337376
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru.
Lanata CF; Black RE; Flores J; Lazo F; Butron B; Linares A; Huapaya A; Ventura G; Gil A; Kapikian AZ
Vaccine; 1996 Feb; 14(3):237-43. PubMed ID: 8920706
[TBL] [Abstract][Full Text] [Related]
9. Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants.
Flores J; Perez-Schael I; Gonzalez M; Garcia D; Perez M; Daoud N; Cunto W; Chanock RM; Kapikian AZ
Lancet; 1987 Apr; 1(8538):882-4. PubMed ID: 2882289
[TBL] [Abstract][Full Text] [Related]
10. Reactogenicity and antigenicity of rhesus rotavirus vaccine (MMU-18006) in newborn infants in Venezuela.
Flores J; Daoud G; Daoud N; Puig M; Martinez M; Perez-Schael I; Shaw R; Greenberg HB; Midthun K; Kapikian AZ
Pediatr Infect Dis J; 1988 Nov; 7(11):776-80. PubMed ID: 2852792
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil.
Linhares AC; Gabbay YB; Mascarenhas JD; de Freitas RB; Oliveira CS; Bellesi N; Monteiro TA; Lins-Lainson Z; Ramos FL; Valente SA
Bull World Health Organ; 1996; 74(5):491-500. PubMed ID: 9002329
[TBL] [Abstract][Full Text] [Related]
12. Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants.
Joensuu J; Koskenniemi E; Vesikari T
Pediatr Infect Dis J; 1998 Apr; 17(4):334-40. PubMed ID: 9576390
[TBL] [Abstract][Full Text] [Related]
13. Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants.
Losonsky GA; Rennels MB; Kapikian AZ; Midthun K; Ferra PJ; Fortier DN; Hoffman KM; Baig A; Levine MM
Pediatr Infect Dis; 1986; 5(1):25-9. PubMed ID: 3003715
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of WC3 rotavirus vaccine and correlates of protection in healthy infants.
Bernstein DI; Smith VE; Sander DS; Pax KA; Schiff GM; Ward RL
J Infect Dis; 1990 Nov; 162(5):1055-62. PubMed ID: 2172394
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants.
Vesikari T; Ruuska T; Koivu HP; Green KY; Flores J; Kapikian AZ
Pediatr Infect Dis J; 1991 Dec; 10(12):912-7. PubMed ID: 1662796
[TBL] [Abstract][Full Text] [Related]
16. Immune protection of infants against rotavirus gastroenteritis by a serotype 1 reassortant of bovine rotavirus WC3.
Clark HF; Borian FE; Plotkin SA
J Infect Dis; 1990 Jun; 161(6):1099-104. PubMed ID: 2161038
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season.
Clark HF; Borian FE; Bell LM; Modesto K; Gouvea V; Plotkin SA
J Infect Dis; 1988 Sep; 158(3):570-87. PubMed ID: 2842405
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a reassortant rhesus rotavirus vaccine in young children.
Tajima T; Thompson J; Wright PF; Kondo Y; Tollefson SJ; King J; Kapikian AZ
Vaccine; 1990 Feb; 8(1):70-4. PubMed ID: 2156387
[TBL] [Abstract][Full Text] [Related]
19. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups.
Madore HP; Christy C; Pichichero M; Long C; Pincus P; Vosefsky D; Kapikian AZ; Dolin R
J Infect Dis; 1992 Aug; 166(2):235-43. PubMed ID: 1321858
[TBL] [Abstract][Full Text] [Related]
20. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
Vesikari T; Rautanen T; Varis T; Beards GM; Kapikian AZ
Am J Dis Child; 1990 Mar; 144(3):285-9. PubMed ID: 2154925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
